As the fifth largest plasma-derived therapies manufacturer in the world, Kedrion collects and processes plasma, selecting and purifying proteins of medical interest and developing them into therapies, ...
CHARLESTON, S.C.--(BUSINESS WIRE)--Plasma Technologies LLC (PlasmaTech), a plasma biologics technology company, announced that its novel human plasma fractionation process has been shown to achieve a ...
The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...
The proteome may be a treasure trove for biomarker discovery, but it is clear that the enormous complexity and dynamic range in protein concentration (10(5)-10(11)) creates a significant challenge for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results